ResearcherUniversity of Eastern FinlandNo recent work listed
Ylermi Soini
Matched on OpenAlex author ID A5113586556. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper
Papers 7
- Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival. Co-author DOI 10.1159/000494274↗
- Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.prp.2018.04.016↗
- KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.21873/anticanres.12474↗
- Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma. Co-author PMID 26722077↗
- Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Co-author DOI 10.1007/s13277-013-1503-7↗
- Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.prp.2013.10.001↗
- Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. Co-author DOI 10.1136/jclinpath-2011-200400↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peeter Karihtala · 6 shared papers, 2014–2019 · strength 0.52
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiati… DOI 10.1159/000494274↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Kirsi‐Maria Haapasaari · 6 shared papers, 2014–2019 · strength 0.52
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiati… DOI 10.1159/000494274↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Joel Isohookana · 3 shared papers, 2016–2018 · strength 0.31
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Paper Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma. PMID 26722077↗
- Joni Leppänen · 1 shared paper, 2018 · strength 0.11
- Norimasa Sawada · 1 shared paper, 2012 · strength 0.03
- Akira Takasawa · 1 shared paper, 2012 · strength 0.03
- Takashi Kojima · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.